Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
ipilimumab to nivolumab
.
Show all posts
Showing posts with label
ipilimumab to nivolumab
.
Show all posts
Tuesday, September 19, 2017
Combo immunotherapy may herald new standard of care for kidney cancer
›
Combination therapy with two immunotherapy drugs produces an unprecedented doubling of response rates from 20 percent to 40 percent, a new...
›
Home
View web version
